PharmaShots | Incisive News in 3 Shots

Subscribe Now

SCLC

Jazz Pharma and PharmaMar's Zepzelca Fail to Meet its Primary Endpoint in P-III ATLANTIS Study for SCLC

Jazz Pharma and PharmaMar's Zepzelca Fail to Meet its Primary Endpoint in P-III ATLANTIS Study for SCLC

December 4, 2020

G1 Therapeutics Reports the US FDA Acceptance and Priority Review of NDA for Trilaciclib to Treat SCLC

G1 Therapeutics Reports the US FDA Acceptance and Priority Review of NDA for Trilaciclib to Treat SCLC

August 18, 2020

Pharma Mar's Zepzelca (lurbinectedin) Receives the US FDA's Accelerated Approval for Adult Patients with Metastatic Small Cell Lung Cancer (SCLC)

Pharma Mar's Zepzelca (lurbinectedin) Receives the US FDA's Accelerated Approval for Adult Patients with Metastatic Small Cell Lun...

June 15, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us